Partial enterectomy decreases somatostatin-binding sites in residual intestine of rabbits by Colás Escudero, Begoña et al.
Clinical Science (1988) 74, 499-505 499 
Partial enterectomy decreases somatostatin-binding sites in 
residual intestine of rabbits 
B. COLAS*, G. BODEGAS?, M. SANZS, J. C. PFUETO" AND E. ARILLA* 
Departamentos de *Bioquimica y Biologia Molecular y tBiologia Celular, Universidad de Alcala de Henares, Madrid, Spain, and 
SServicio de Cirugia 11, Hospital Clinico, Universidad Complutense, Madrid, Spain 
(Received 7 Apri1/28 September 1987; accepted 21 October 1987) 
SUMMARY 
1. Three weeks after partial enterectomy in the rabbit 
there was an increased somatostatin concentration and a 
decreased number of somatostatin-binding sites (without 
changes in the corresponding affinity values) in the 
cytosol of the residual intestinal tissue, except in the 
terminal ileum and the colon. 
2. Five weeks after surgery both the somatostatin con- 
centration and the number of somatostatin-binding sites 
returned towards control values. 
3. These results suggest that an increase in bowel 
somatostatin content could lead to down-regulation of 
somatostatin-binding sites in the intestinal mucosa. 
Key words: cytosol, enterectomy, somatostatin binding. 
Abbreviation: SLI, somatostatin-like immunoreactivity. 
INTRODUCTION 
Somatostatin, originally isolated from the hypothalamus 
[ 11, is also distributed throughout the gastrointestinal tract 
[2] in nerve fibres as well as in endocrine cells (D) [3,4]. 
Endocrine D-cells are scattered in the mucosa in close 
proximity to other peptide-containing endocrine cells [5, 
61. Studies in vivo and in vitro have shown that somato- 
statin inhibits a number of gastrointestinal functions [7]. 
Recent observations suggest that in the gastric antrum a 
decrease in luminal pH stimulates growth of somatostatin 
cells [8]. Furthermore, it has been shown that intestinal 
somatostatin release is directly stimulated by nutrients [9]. 
Resection of a large segment of small intestine is asso- 
ciated with a low pH of jejunal content [ lo ]  as well as an 
increased quantity of food residue in the lower bowel [ l  13. 
However, the effect of partial enterectomy on somato- 
Correspondence: Professor E. Arilla, Departamento de Bio- 
quimica y Biologia Molecular, Universidad de Alcala de 
Henares, Madrid, Spain. 
statin concentration in the residual intestine is still 
unknown. On the other hand, an important mechanism 
for controlling hormonal sensitivity is the regulation of 
hormone-binding sites by the homologous hormone [ 121. 
In this context, the regulation of its own binding sites has 
not been demonstrated for somatostatin in the intestinal 
tract. We have recently shown the existence of specific 
binding sites for somatostatin in the cytosolic fraction iso- 
lated from intestinal mucosa [ 13, 141. These somatostatin- 
binding sites showed a remarkable degree of specificity. 
High concentrations (1 ,umol/l) in the intestinal tract of 
neuropeptides such as neurotensin, [Leu]enkephalin, sub- 
stance P and vasoactive intestinal peptide showed little 
affinity for somatostatin-binding sites. 
The purpose of the present study was to determine the 
effects of intestinal resection on somatostatin content 
throughout the residual small intestine and large bowel, as 
well as the possible regulation by somatostatin of its own 
binding sites in these tissues. 
MATERIALS AND METHODS 
Chemicals 
Somatostatin-14 was kindly provided by Serono 
(Spain). Synthetic [Tyr' llsomatostatin was purchased from 
Universal Biologicals Ltd (Cambridge, U.K.). Trypsin 
inhibitor and bovine serum albumin were from Sigma (St 
Louis, MO, U.S.A.), T-70 dextran from Pharmacia Fine 
Chemicals (Uppsala, Sweden), activated charcoal from 
Feinbiochemica (Heidelberg, F.R.G.) and carrier-free 
NaIz5I (IMS 30, 100 mCi/ml) was from the Radio- 
chemical Centre (Amersham, U.K.). [Tyrll]Somatostatin 
was radioiodinated by a chloramine-T method [15] at a 
specific radioactivity of about 350 Ci/g. The rabbit anti- 
body used in the radioimmunoassay technique was 
purchased from the Radiochemical Centre (Amersham, 
U.K.). This antiserum was raised in rabbits against 
somatostatin-14 conjugated to bovine serum albumin and 
is specific for somatostatin but, as somatostatin-14 consti- 
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tutes the C-terminal portions of both somatostatin-25 and 
somatostatin-28, the antiserum does not distinguish 
between these three forms. All other chemicals were 
reagent grade. 
Procedures 
Resection. Male rabbits (New Zealand) weighing 1-2 kg 
were fasted and allowed to drink only water for 24 h. After 
they were anaesthetized with Ketaminc hydrochloride, the 
rabbits were subjected to one of two operative procedures. 
In one group, the small intestine was resected from 10 cm 
distal to the ligament of Treitz to 10 cm proximal to the 
ileocaecal valve. Intestinal continuity was re-established by 
anastomosis of the proximal jejunal segment to the terminal 
ileum. In the second group (sham-operated or control 
group), a laparatomy was performed. 
Subcellular fractions. Control as well as resected 
animals were studied at 1, 3 and 5 weeks after surgery. 
Gut segments corresponding to the whole duodenum, 
proximal jejunum, distal ileum, colon and rectum were 
immediately removed and incubated at 37°C for 30 min 
in a 10% suspension (w/w) in ice-cooled 10 mmol/l 
Tris-250 mmol/l sucrose buffer, pH 7.4, containing 
trypsin inhibitor (0.1 mg/ml) and then subsequently 
washed twice in the same suspension in order to remove 
endogenous somatostatin. The cytosol was isolated 
according to the method of Reyl-Desmars & Lewin [ 161. 
Homogenates were prepared from intestinal wall using a 
motor-driven Potter-Elvehjem Teflon-glass homogenizer 
(1 min at 1800 rev./min) in the suspension described 
above. The homogenates were then centrifuged for 1 h at 
105 000 g. The protein concentration in the cytosol was 
estimated by the method of Lowry et uf. [ 171 using bovine 
serum albumin as a standard. Results were expressed as 
somatostatin-like immunoreactivity (SLI) per ng of 
protein. 
Binding studies. The cytosolic fractions (0.2 mg of 
protein/ml) were incubated at 25°C for 90 min in 0.5 ml 
of a medium (pH 7.4) of the following composition (in 
mmol/l): NaH,PO, 0.5, Na,HPO, 1, NaCl 80, KCI 5, 
CaClz 1, MgClz 1.5, 4-(2-hydroxyethyl)-l-piperazine- 
ethanesulphonic acid 50, glucose 11, and containing 
bovine serum albumin (0.Io/o, w/v), trypsin inhibitor (0.01 
mg/ml) and '2s1-labelled [Tyr' ']somatostatin (50 pmol/l). 
The fractions were incubated either alone or together 
with increasing concentrations of unlabelled somatostatin 
(up to 2 pmol/l). Unbound peptide was removed by 
adding 1 ml of 0.25% (w/v) activated charcoal, 0.5% (w/v) 
bovine serum albumin and 0.025% (w/v) T70 dextran [ 18, 
191. 'Specific' binding was estimated as the difference 
between 'total' binding (i.e. in the presence of tracer alone) 
and 'non-specific' binding (as measured in the presence of 
4 pmol/l unlabelled somatostatin); this non-specific com- 
ponent represented about 45% of the binding observed in 
the absence of unlabelled somatostatin. The integrity of 
bound '2sI-labelled [Tyr' ']somatostatin was assessed by talc 
adsorption [ 131. 
Tissue extraction and radioimmunoassay. Somato- 
statin was extracted in 1 mol/l acetic acid at 0°C by soni- 
cation. The homogenate was centrifuged at 3000 rev./min 
for 30 min at 4"C, and the resultant supernatant was 
stored at -70°C until assay. Just bcfore assay, extracts 
were neutralized with 1 mol/l NaOH. Somatostatin con- 
centration was determined in tissue extracts by a radio- 
immunoassay method [20] with a limit of sensitivity of 10 
pg/ml. Incubation tubes were prepared in triplicate and 
the following were added to assay tubes in sequence: 200 
pl of sample or standard containing 0-320 pg of cyclic 
somatostatin, 200 p1 of '2sI-labelled [Tyr"]somatostatin 
(5000 c.p.m., equivalent to 5-10 pg), and 400 pl of 
appropriately diluted antibody (final dilution usually 
1 : 20 000). After brief vortexing, the tubes were incubated 
at 4°C for 48 h; separation of bound and free hormone 
was accomplished by addition of 500 pI of dextran- 
coated charcoal (dextran: 0.025%, w/v; Pharmacia T-70, 
Uppsala, Sweden; charcoal: Norit A, 0.25%, w/v; Serva, 
Feinbiochemica, Heidelberg, F.R.G.). Dilution curves for 
rabbit tissue extracts were parallel to the standard curve. 
The intra-assay and interassay coefficients of variation 
were 6.8% and 10.2%, respectively. 
Statistical analysis 
Each individual experiment was performed in tripli- 
cate. Results are expressed as mean v a l u e s k ~ ~ ~ .  The 
linear equations used to describe the Scatchard plots [21] 
were determined by standard linear regression analysis. 
The statistical significance of difference of the means was 
determined by the Student's t-test; differences of P< 0.05 
were assumed to be significant. 
RESULTS 
The influence of small intestinal resection on SLI concen- 
tration in the residual duodenum, jejunum, ileum, 
caecum, colon and rectum is shown in Figs. 1 and 2. 
Three weeks, but not 1 week, after surgery, with the 
exception of the ileum and colon, the intestinal somato- 
statin concentration was significantly higher in the 
animals that underwent resection than in the sham- 
operated animals ( P <  0.05). Five weeks after resection, the 
concentration of somatostatin had returned to control 
values throughout the intestinal tract. 
The cytosolic fraction from both sham-operated and 
resected rabbits bound 12sI-labelled [Tyr' ']somatostatin 
by a time-dependent process. An apparent equilibrium 
was observed between 60 and 120 min at 25°C (data not 
shown). All subsequent binding studies were therefore 
conducted at 25°C for 90 min. 
Different somatostatin-degrading activities in the cyto- 
solic preparations studied could affect the interpretation 
of the results. For this reason, the degradation of the 
peptide by cytosolic fraction of the six types of extracts 
were studied. A similar extent of degradation (between 25 
and 30%) was observed in all six extracts. Specific binding 
of '251-labelled [Tyr' ']somatostatin was reversible once 
formed, since the complex labelled peptide-cytosolic 
fraction could dissociate upon addition of an excess of 
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Fig. 1. Effect of partial enterectomyonSL1 concentrationin 
rabbit duodenum (a), proximal jejunum ( b )  and distal ileum 
(c). The controls (0) and resected (m) animals were studied 
at 1 ,3  and 5 weeks after surgery. Values are expressed as 
means k SEM of four triplicate determinations. Statistical 
significance: * P <  0.05 vs control value. 
unlabelled somatostatin (4 pmol/l). The dissociation 
patterns from the cytosolic preparation of sham-operated 
and resected rabbits were not statistically significantly dif- 
ferent (data not shown). The time at which 50% of the 
specifically bound 1251-labelled [Tyr' l]somatostatin dis- 
sociated from the cytosolic fraction varied between 19 
and 22 min and no significant differences could be estab- 
lished when comparing all six types of extracts. 
Increasing concentrations of unlabelled somatostatin 
competitively inhibited the specific binding of 1251- 
labelled [Tyrl l]somatostatin to the cytosolic fraction of 
intestinal mucosa (Figs. 3 and 4). Except in the terminal 
ileum and the colon, specific binding of 12SI-labelled 
[Tyrll]somatostatin to the cytosolic fractions 3 weeks after 
resection was significantly lower than that in the control 
group, both in the absence or presence of unlabelled 
somatostatin (1 nmol/l-2 pmol/l). However, 5 weeks after 
resection, binding values were similar in both conditions. 
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Fig. 2. Effect of partial enterectomy onSLIconcentrationin 
rabbitcaecum(a),colon(b)andrectum(c).Thecontrols(~) 
and resected (0) animals were studied at 1,3 and 5 weeks 
after surgery. Values are expressed as means k SEM of four 
triplicate determinations. Statistical significance: *P< 0.05 
vs control values. 
jected to Scatchard plot [21], the values of somatostatin 
binding to the cytosolic preparations exhibited curvi- 
linear, concave-upward curves (not shown) that were 
analysed on the basis of two classes of binding sites. A 
least-squares regression line was drawn to fit the low- 
affinity site using the four higher somatostatin concentra- 
tions. The contribution of this site was subtracted from the 
binding obtained at the lower somatostatin concentra- 
tions to obtain the high-affinity binding. Tables 1 and 2 
show the corresponding equilibrium parameters for the 
high-affinity, low-capacity and for the low-affinity, high- 
capacity binding sites. From these results the decrease in 
somatostatin binding to the cytosolic fraction of intestinal 
mucosa 3 weeks after surgery must be accounted for by a 
decreased number of both high- and low-affinity binding 
sites rather than a change in their corresponding affinities. 
In order to determine whether in the binding experiments 
the apparent decrease in somatostatin-binding sites is due 
to occupancy of sites by endogenous somatostatin, cyto- 
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Fig. 3. Competitive inhibition of specific '251-labelled [Tyr' ']somatostatin (50 pmol/l) binding to 
mucosal cytosol(0.2 mg of protein/ml) from rabbit duodenum (a),  proximal jejunum ( b )  and distal 
ileum( c) by unlabelled somatostatin. Data correspond to control rabbits ( 0 )  and animals subjected to 
small bowel resection and studied 1 (O), 3 (A )and 5 ( A ) weeksafter surgery. Each point is the mean of 
fiveseparateexperiments, each performed in triplicate.For thesakeofclarity,sEM arenot represented 
but were always below 10% of the mean values. 
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Fig. 4. Competitive inhibition of specific '2s1-labelled [Tyr' ']somatostatin (50 pmol/l) binding to 
mucosal cytosol(0.2 mg of protein/ml) from rabbit caecum( a) ,  colon( b)  and rectum( c) by unlabelled 
somatostatin. Data correspond to control rabbits ( 0 )  and animals subjected to small bowel resection 
and studied 1 (O), 3 (A ) and 5 ( A )weeks after surgery. Each point is the mean of five separate experi- 
ments, each performed in triplicate. For the sake of clarity, SEM are not represented but were always 
below 10% of the mean values. 
solic Somatostatin concentration was measured by radio- 
immunoassay. The somatostatin content was so low as to 
be mostly undetectable. 
DISCUSSION 
Present results provide evidence that, except in the 
terminal ileum and colon, the somatostatin content of the 
intestinal wall increased 3 weeks after small bowel re- 
section, whereas the number of somatostatin-binding sites 
decreased without any change in their affinity. Five weeks 
after resection, intestinal somatostatin content as well as 
the number of somatostatin-binding sites had returned 
towards control values. 
The changes in duodenal and jejunal somatostatin after 
intestinal resection differ from those observed by Gelinas 
et al. [22] in rats. These workers did not demonstrate any 
effect of enterectomy on somatostatin concentration in 
small intestinal mucosa. The discrepancies may be 
explained in a number of different ways: (a) Gelinas et a[. 
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Table 1. Equilibrium parameters of somatostatin binding in the cytosol of rabbit intestinal mucosa after small bowel 
resection 
Binding parameters were derived from the experimental data in Fig. 3. Results are m e a n s k ~ ~ ~  ( n = 5 ) .  Statistical 
significance: * P <  0.05 vs control value. Abbreviation: K,,dissociationconstant. 
Duodenum Proximal jejunum Distal ileum 
High-affinity Low-affinity High-affinity Low-affinity High-affinity Low-affinity 
binding sites binding sites binding sites binding sites binding sites binding sites 
Control 
K ,  (nmol/l) 22.3 f 2.3 169f17  20.1 f 1.6 209 f 14 13.0 f 0.4 1 9 5 f 4  
Binding capacity (pmol/mg of 3.3 f 0.2 134+ 11 3.2 + 0.5 159+ 10 1.6 f 0.1 103+3 
protein) 
1 week after resection 
K ,  (nmol/l) 23.2 f 2.4 156f18  20.0 f 2.0 226 + 32 9.0 -1 3.2 195+15 
Binding capacity (pmol/mg of 3.7 f 0.6 149+ 14 3.0 k 0.4 167-125 1.6f0.3 9 8 f 1 0  
protein) 
3 weeks after resection 
K ,  (nmol/l) 21.8 f 3.4 156f 19 24.0 f 4.2 269 + 30 12.5-11.3 183+ 10 
Binding capacity (pmol/mg of 1.7 + 0.4* 6 3 f 1 0  1.3 + 0.5* 8 7 f 1 8  1.5 rt: 0.2 81 f 10 
protein) 
5 weeks after resection 
K ,  (nmol/l) 24.1 f 0.2 184+ 12 20.4 f 0.5 213f30  10.2 f 0.2 204 f 28 
Binding capacity (pmol/mg of 2.6 + 0.3 148+23 3.2 + 0.5 122f12  2.3 + 0.5 123f 16 
protein) 
Table 2. Equilibrium parameters of somatostatin binding in the cytosol of rabbit intestinal mucosa after small bowel 
resection 
Binding parameters were derived from the experimental data in Fig. 4. Results are m e a n s k ~ ~ ~  ( n  = 5). Statistical 
significance: * P <  0.05 vs control value. Abbreviation: K , ,  dissociation constant. 
Caecum Colon Rectum 
High-affinity Low-affinity High-affinity Low-affinity High-affinity Low-affinity 
binding sites binding sites binding sites binding sites binding sites binding sites 
Control 
K, (nmol/l) 22.7 + 4.2 172+18 20.8 f 8.0 224 k 25 12.6 + 0.2 173+18 
Binding capacity (pmol/mg of 3.0 k 0.6 102 f 7 2.6 f 0.2 192 f 14 1.9 kO.1 185+ 19 
protein) 
1 week after resection 
184f 10 K ,  (nmol/l) 23.0 k4.4 174f30  22.5 + 5.0 190+68 10.6 f 0.4 
Binding capacity (pmol/mg of 3.2 f 0.4 97+7 2.5 + 1.3 158+3 1.6f0.2 178+ 17 
protein) 
3 weeks after resection 
K ,  (nmol/l) 20.0 k 4.0 186+7 23.4 f 2.5 219k47 9.8 + 0.5 200 + 48 
Binding capacity (pmol/mg of 1.5 + 0.2* 40+ 1* 2.2 f 0.4 146+ 13 1.0+0.3* 61 +6* 
protein) 
5 weeks after resection 
K ,  (nmol/l) 21.7 + 4.2 185+8 10.6 f 0.4 209 + 67 10.6 f 0.4 206 + 7 
Binding capacity (pmol/mg of 2.3 f 0.2 9 0 f 3  l.6k0.2 158f17  1.6f0.2 153f 17 
protein) 
assayed isolated mucosa, whereas we used the whole sistent with the previous results of Gregor et al. [23]. 
intestinal wall, (b) different operative techniques were Murphy et al. [24] have shown that other peptides such as 
used and different amounts of gut were resected, (c) there secretin and vasoactive intestinal peptide are increased in 
is a species difference, and (d) studies were made at the duodenum and ileum, respectively, after intestinal 
different time intervals after enterectomy. The lack of any resection. The reason for the increase in intestinal 
significant difference in somatostatin content of the somatostatin concentration observed 3 weeks after enter- 
colonic mucosa in resected and control animals is con- ectomy remains unclear. It is not known whether the 
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increase in somatostatin after small bowel resection is a 
secondary adaptation to the loss of the intestinal D-cells 
which are numerous in the rabbit [25]. Recent data 
suggest that a decrease in the intraluminal pH could be a 
stimulant for D-cell growth [8] and partial enterectomy is 
associated with a low pH of small bowel content [lo]. 
Previous results, together with previous studies show- 
ing that somatostatin inhibits intestinal mucosal growth 
and differentiation [26], suggest that somatostatin could 
play a role in intestinal adaptation after small bowel resec- 
tion. However, whether these modifications are a conse- 
quence or a cause of the intestinal adaptative response 
remains to be elucidated. 
There is strong evidence that rat anterior pituitary 
somatostatin is internalized by its target cells [27] and that 
at least some of the effects of somatostatin in the intestinal 
mucosa are mediated through the intervention of intra- 
cellular binding sites coupled with phosphoprotein phos- 
phatase units [ 19,281. 
Although the affinity values for the intestine are not 
compatible with the low circulating levels of the peptide, it 
should be borne in mind that somatostatin is present in 
both paracrine cells and nerve endings [2-41 within the 
intestinal wall. This neuroparacrine condition may permit 
sufficiently large local concentrations of somatostatin to 
facilitate interaction with the reported binding sites. 
The observed high levels of intestinal somatostatin 
could result in a much increased local somatostatin 
release. In this context, a low pH of the small bowel con- 
tents [29] as well as an increased presence of food residue 
in lower gut [9] stimulate somatostatin release, both 
factors being present after small bowel resection [ lo ,  111. 
Furthermore, involvement of other factors such as 
elevated circulating levels of cholecystokinin [30] and 
secretin [3 11 observed after small bowel resection cannot 
be ruled out, since both hormones are known to stimulate 
somatostatin release [32, 331. Our results are consistent 
with the recent data of Srikant & Heisler [34], showing 
that prolonged exposure of pituitary tumour cells (which 
contain somatostatin-binding sites) to somatostatin 
resulted in a marked decrease of the number of somato- 
statin-binding sites. Our results are also consistent with 
the evidence that hypothalamic somatostatin release 
causes a reduction in the capacity (but not in the affinity) 
of somatostatin-binding sites in rat pituitary membranes 
[35]. Furthermore, up-regulation of somatostatin-binding 
sites has been demonstrated to be associated with deple- 
tion of endogenous somatostatin after cysteamine admini- 
stration ill vivo [36]. 
This report describes for the first time the effect of 
extensive enterectomy on somatostatin in intestinal tissue. 
The physiological meaning of these findings remains 
unclear, since the role of altered binding site capacity in 
modulating the effects of intestinal somatostatin has not 
been evaluated. 
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